Previous studies have shown that C3 subtypes are associated with the most favorable prognosis, due to the type I immune response needed for cancer control (56) as well as the most pronounced Th17 signature (57), C2 was IFN-γ dominant and showed a less favorable survival outcome compared to C3 (34). Here, IFNG is linked to cancer.